Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences
Login
Close

Meghan Oates-Zalesky 

Meghan Oates‑Zalesky is Chief Marketing Officer at CapeStart and MadeAi, with over 20 years of experience in healthcare technology and life sciences. Previously CMO at Apollo Intelligence, she helped grow the company from a small startup into a global enterprise. A PharmaVOICE Woman of Influence (2021), Meg’s thought leadership has appeared in leading industry publications. She holds degrees from Harvard and the London School of Economics and is a published novelist and avid equestrian.

67 articles published Follow:
MadeAi

MadeAi™ Unveils New Capabilities for GVD and JCA Reporting, Setting a New Benchmark for Life Sciences GenAI-Enabled Evidence Synthesis and Reporting

MadeAi Press ReleaseNovember 10, 2025119Views0Likes0Comments
GLASGOW, SCOTLAND and CAMBRIDGE, MA, USA, November 10, 2025—At ISPOR Europe 2025 today, MadeAi™, the GenAI-powered evidence synthesis and report generation platform for life sciences, announced the launch of new capabilities designed to streamline and accelerate global value dossier (GVD) and Joint Clinical Assessment (JCA) submissions. With these advancements, MadeAi delivers the most comprehensive, AI-native…

Read More

Accuracy in GenAI-Based Literature Review Systems

Accuracy in GenAI-Based Literature Review Systems

White PaperNovember 6, 2025135Views0Likes0Comments
Accuracy and methodological rigor define the credibility of GenAI-based literature review systems. MadeAi-LR establishes a measurable framework for assessing AI reliability, minimizing hallucinations, and ensuring scientifically validated outcomes across every stage of evidence synthesis. Download Accuracy in GenAI-Based Literature Review Systems to discover the metrics, methodologies, and best practices shaping the next generation of trustworthy…

Read More